Related references
Note: Only part of the references are listed.Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality
Zitta Barrella Harboe et al.
CLINICAL INFECTIOUS DISEASES (2014)
A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses
Hideaki Shima et al.
INTERNATIONAL IMMUNOLOGY (2014)
Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology
Alice S. Zhao et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2014)
Serotype-independent pneumococcal vaccines
Eliane Namie Miyaji et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae
Il Gyu Kong et al.
INFECTION AND IMMUNITY (2013)
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium
N. A. Mabbott et al.
MUCOSAL IMMUNOLOGY (2013)
Characterization of Protective Immune Responses Induced by Pneumococcal Surface Protein A in Fusion with Pneumolysin Derivatives
Cibelly Goulart et al.
PLOS ONE (2013)
Gut-associated lymphoid tissues for the development of oral vaccines
Jun Kunisawa et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Novel vaccine development strategies for inducing mucosal immunity
Yoshiko Fujkuyama et al.
EXPERT REVIEW OF VACCINES (2012)
Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice
Chung Truong Nguyen et al.
VACCINE (2011)
Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells
Cibelly Goulart et al.
VACCINE (2011)
Mucosal vaccination using claudin-4-targeting
Hideki Kakutani et al.
BIOMATERIALS (2010)
Immunization of Mice with Single PspA Fragments Induces Antibodies Capable of Mediating Complement Deposition on Different Pneumococcal Strains and Cross-Protection
Adriana T. Moreno et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Challenges in reducing the burden of otitis media disease: An ENT perspective on improving management and prospects for prevention
Gerhard Grevers
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2010)
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Thejani E. Rajapaksa et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Secretory-IgA Antibodies Play an Important Role in the Immunity to Streptococcus pneumoniae
Yoshiko Fukuyama et al.
JOURNAL OF IMMUNOLOGY (2010)
A New Pneumococcal Serotype, 11E, Has a Variably Inactivated wcjE Gene
Juan J. Calix et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Molecular Basis of the Core Structure of Tight Junctions
Mikio Furuse
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response
Koji Hase et al.
NATURE (2009)
Immunological commonalities and distinctions between airway and digestive immunity
Jun Kunisawa et al.
TRENDS IN IMMUNOLOGY (2008)
Structure of the claudin-binding domain of Clostridium perfringens enterotoxin
Christina M. Van Itallie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses
Tomonori Nochi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Induction of secretory immunity and memory at mucosal surfaces
Per Brandtzaeg
VACCINE (2007)
Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin
James G. Smedley et al.
INFECTION AND IMMUNITY (2007)
Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae
In Ho Park et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model
Abiodun D. Ogunniyi et al.
INFECTION AND IMMUNITY (2007)
Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4
A Takahashi et al.
JOURNAL OF CONTROLLED RELEASE (2005)
A novel strategy for the enhancement of drug absorption using a claudin modulator
M Kondoh et al.
MOLECULAR PHARMACOLOGY (2005)
PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin
M Shaper et al.
INFECTION AND IMMUNITY (2004)
Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment
AI Ivanov et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
The viral σ1 protein and glycoconjugates containing α2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces
A Helander et al.
JOURNAL OF VIROLOGY (2003)
M cell DNA vaccination for CTL immunity to HIV
XH Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
GS Nabors et al.
VACCINE (2000)
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
DE Briles et al.
INFECTION AND IMMUNITY (2000)
Share Paper
